These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24470347)

  • 1. Identification and characterization of the process-related impurities in fasudil hydrochloride by hyphenated techniques using a quality by design approach.
    Song M; Chen YQ; Lu PB; Hang TJ
    J Sep Sci; 2014 Apr; 37(7):758-63. PubMed ID: 24470347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of the related substances in fasudil hydrochloride with hyphenated techniques].
    Chen YQ; Song M; Hang TJ
    Yao Xue Xue Bao; 2013 Mar; 48(3):401-5. PubMed ID: 23724655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, synthesis and quantification of process-related impurities in auraptene.
    Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
    J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M; Cindrić M; Koruznjak JD
    J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitative analysis of fasudil and its active metabolite in human plasma by liquid chromatography electro-spray tandem mass spectrometry.
    Chen H; Lin Y; Han M; Bai S; Wen S
    J Pharm Biomed Anal; 2010 Jun; 52(2):242-8. PubMed ID: 20080374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Mar; 90():27-34. PubMed ID: 24333703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the impurities and isomers in cefetamet pivoxil hydrochloride by liquid chromatography/time-of-flight mass spectrometry and ion trap mass spectrometry.
    Wang D; Wang F; Wang J
    J Pharm Biomed Anal; 2015; 111():71-7. PubMed ID: 25863019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan.
    Feng WD; Zhuo SM; Zhang FL
    J Pharm Biomed Anal; 2019 Feb; 165():325-337. PubMed ID: 30579233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS.
    Rao RN; Raju AN; Narsimha R; Babu GR
    J Sep Sci; 2008 Jan; 31(1):107-18. PubMed ID: 18080239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and control of eight process-related and two genotoxic fingolimod impurities by a validated RP-UPLC method.
    Bellur Atici E; Yazar Y; Rıdvanoğlu N
    Biomed Chromatogr; 2022 Apr; 36(4):e5316. PubMed ID: 34981532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.